IBB DOWN market verdict | Ezbrisk

Published: 1785509398336

Anomaly score: -2.3690067081741835

Confidence: 0.75

Market summary

RNA Forecast Cut Drags Biotech

Ezbrisk assessment

A major constituent specializing in RNA therapies lowered its full-year revenue guidance, sparking broader concerns about normalized drug demand and weighing sharply on the sector.

Sources: https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEx_OeHhKVcHNXc8bM1ySt4CPU4fkrB2bLMjvOWwTr0oQSAOl7BuUh_yUqXm_ptASQk-Qz6ry6gLqY4fCdytZwrRLik0V2aEr93WG6Gx8P81NqkTBg6rHrUGd2QPuCesIA0WpkMCRauxfEwZWPAw-jfSwiWNM95sOHu2JROBPNfhS68yv1ZZBWmg9RjvEbDrAsvHbY5UaH0Z34btNE=, https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQHxrZvpI_DeJtWXmY48pLrpl9VfnDcDMATgOGvy52IF4T1y9ybV5-HTrIQKTq3OzxRuNKM3GCTRe2tPQu_JRzTqiDuGwGPtandQ0qB3rIkoXYg7UACTghcX_ci_0iHx3bG-tnZryI4Dhb7O1fIuam_W4I5m20UD_VF-qlKVZlCXuWHCXWeDduU7QFn_XOvRjiTOIcyP9tu7BML-8c9YVtsDWv4KGxwP, https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEKBzpEzjQF3XHxNT5TPvNHeqsfo6IUdFTK253DeAmc0Z3RSVUbSOuhmL4DaABa0Iz6kZeIrKQ_wO03gQtFRiDwoEqb9yOyoYXhkIl0DnOTJkYjG6O8c1yBLl9RMEXIjw0Mpv2_gn7PbpP8pfyZ-5HB9duT4ow7NKGwSBZp7Jyl2zNxN6T41xLEvNS9a8nBs5kRLbRqgqWEoMrFgDIYVVIZlP7bwabZIUdyZoW5QFz93fbnCjW9EFlFxEoRlH5yn2HObt8iJUQF7ehbLwQ=

Verdict ID: 033e09a0-97ba-4f01-9101-8b78a8ddbaf3